MATTHEW GRAZIANO: Open Payments
NPI 1316992985 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$292 in 23 payments from 6 companies in 2025. Trend: 2023 $354 · 2024 $320 · 2025 $292
Food & beverage: $292
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 15 | $135 |
| Boston Scientific Corporation | 2 | $48 |
| PFIZER INC. | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: REPATHA, VYNDAQEL, LEQVIO, WATCHMAN, WATCHMAN FLX, ELIQUIS, Kerendia.
Industry payments across NY — which companies pay providers there.
